INFECTION and IMMUNITY 2025
Chairs: Nikki Moreland & Sophie Valkenburg
Sponsored by:
Developing the R21/Matrix-M malaria vaccine (#3)
4:00 PM
SToP (See, Treat, and Prevent) activities for impetigo control in remote Western Australia: a cluster randomised, stepped-wedge Trial (#4)
4:25 PM
Development of mRNA vaccines for hepatitis C virus (#5)
4:50 PM
Insights from Immunotherapeutics for Cancer and Autoimmune Diseases: Adapting Approaches for Infectious Diseases (#6)
5:05 PM
Structural characterisation of anti-JEV human antibody epitopes reveals a new target for broad spectrum therapies and vaccines. (#7)
5:20 PM
FECAL MICROBIAL TRANSPLANTATION IN PROTECTION FROM RECURRENT C. DIFFICILE INFECTION (#8)
5:35 PM
Personalised cell membrane vaccine combined with precision nanomedicine for enhanced immunotherapy (#9)
5:50 PM